Iovance Biotherapeutics
IOVA
IOVA
249 hedge funds and large institutions have $462M invested in Iovance Biotherapeutics in 2025 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 81 increasing their positions, 76 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 41
1% less funds holding
Funds holding: 252 → 249 (-3)
7.1% less ownership
Funds ownership: 65.94% → 58.84% (-7.1%)
Holders
249
Holding in Top 10
3
Calls
$7.47M
Puts
$4.47M
Top Buyers
| 1 | +$9.09M | |
| 2 | +$7.42M | |
| 3 | +$5.9M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$4.88M |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$4.88M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$8.41M | |
| 3 | -$5.87M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.96M |
| 5 |
Two Sigma Investments
New York
|
-$4.11M |
